Zickermann, Ruth
Ferati, Mexhid
Fan, Ningbo
Plamper, Evelyn
Datta, Rabi
Lyu, ZiCheng
Horstmann, Nellie
Lohmann, Judith
Pickert, Lena
Loh, Kah Poh
Battisti, Nicolò Matteo Luca
Shen, HuiXia
Göde, Valentin
Iyú, David
Bruns, Christiane
Polidori, M. Cristina
Zhao, Yue
Funding for this research was provided by:
Universitätsklinikum Köln
Article History
Received: 2 May 2025
Accepted: 10 May 2026
First Online: 13 May 2026
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and was approved by the ethic committee of Medical Faculty of University of Cologne (ID: 21-1169). The informed consent to participate was obtained from all of the participants in the study.
: Not applicable.
: N.M.L.B: Advisory board: Pfizer, Abbott, Sanofi, Astellas; travel grants: Exact Sciences, Pfizer, Lilly, Novartis; speaker fees: Pfizer, AbbVie, Roche, Sanofi, Novartis, Servier, Gilead, AstraZeneca, Lilly, Exact Sciences K.P.L: Consultant: Pfizer and Seagan; Honoraria: PfizerV.G.: Astra Zeneca, AbbVie, Novartis, Merck, Norgine, Berlin Chemie The remaining authors declare that they have no competing interests.
: Not applicable.